Associate Director, Global Regulatory Affairs Project Lead - Trenton, United States - Genmab A/S

    Default job background
    Description
    The Genmab Vacancy Website is hosted by our Global HR System vendor, Workday. If you have any questions related to the hosting of this site please contact us at

    .
    Associate Director/Senior Manager, Global Regulatory Affairs Project Lead page is loaded

    Associate Director/Senior Manager, Global Regulatory Affairs Project Lead

    Apply

    locations

    Copenhagen

    time type

    Full time

    posted on

    Posted Yesterday

    job requisition id

    R10078


    At Genmab, we're committed to building extra[not]ordinary futures together, by developing antibody products and pioneering, knock-your-socks-off therapies that change the lives of patients and the future of cancer treatment and serious diseases.

    From our people who are caring, candid, and impact-driven to our business, which is innovative and rooted in science, we believe that being proudly unique, determined to be our best, and authentic is essential to fulfilling our purpose.

    The Role & Department

    As a Senior Manager/Associate Director, Global Regulatory Affairs Project Lead you will be a part of our Global Regulatory Affairs organization.

    In this role, you will represent RA in the Clinical Trial Teams and work closely with the CRO and internal stakeholders to ensure regulatory oversight and progress of the clinical trial submissions in EU/ROW.

    The chosen candidate may also be allocated as EU/ROW regulatory strategy lead to one or multiple compounds in early development and provide regulatory expertise and guidance on EU/ROW procedural matters and documentation requirements to the Global Regulatory Team and Compound Development Team to ensure an optimal EU/ROW regulatory strategy for the compound.

    This position will report to the Global Regulatory Strategy Team Lead.

    Key responsibilities include
    Represent RA in the Clinical Trial Teams and ensure oversight and progress of multiple, often highly complex, clinical trial submission activities

    Represent EU/ROW in the Global Regulatory Team(s)

    Act as EU/ROW regulatory lead for the assigned project(s) and be responsible for the development and execution of the EU/ROW strategy

    Lead the preparation of strategic regulatory documents, e.g. Briefing Packages, ODDs, PIPs, etc

    Plan, prepare and lead EMA or national Scientific Advice procedures, as relevant

    Evaluate regulatory risks and recommend mitigation strategies to the cross-functional teams and management

    Monitor and assess regulatory guidelines and regulations and current regulatory

    environment/landscape

    and their impact on the development of Genmab products

    Maintain an updated knowledge of

    regulatory topics

    and regulations and participate in maintaining and preparing regulatory processes and ways of working

    Requirements
    A minimum of Bachelor's degree or equivalent in scientific discipline or health-related field. Master's degree preferred

    Minimum of 5 years of experience in Regulatory Affairs, preferably in development phase

    Experience in proactively planning and executing highly complex clinical submission strategies

    A good understanding of drug development and EU regulatory procedures. Experience within oncology will be a plus

    Prior experience leading health authority meetings with the EMA or other health authorities. Experience with PIPs will be a plus

    Strong project management skills

    Moreover, you meet the following personal requirements:
    Strong organizational, communication, and time management skills needed to manage multiple ongoing projects simultaneously

    Must have attention to detail and be able to solve problems with minimal supervision

    Be able to work independently with an ability to drive projects to successful outcomes

    Robust cross-functional teamwork skills and enjoy working in a global environment

    Skills in building and maintaining internal and external collaborative relationships to achieve shared goals

    Highly motivated and self-driven individual who enjoys being challenged

    Able to prioritize your work in a fast paced and changing environment

    Goal-oriented and committed to contributing to the overall success of Genmab

    This role is located in Copenhagen, Denmark and is hybrid.
    About You
    You are passionate about our purpose and genuinely care about our mission to transform the lives of patients through innovative cancer treatment
    You bring rigor and excellence to all that you do. You are a fierce believer in our rooted-in-science approach to problem-solving
    You are a generous collaborator who can work in teams with diverse backgrounds
    You are determined to do and be your best and take pride in enabling the best work of others on the team
    You are not afraid to grapple with the unknown and be innovative
    You have experience working in a fast-growing, dynamic company (or a strong desire to)
    You work hard and are not afraid to have a little fun while you do so
    Locations
    Genmab leverages the effectiveness of an agile working environment, when possible, for the betterment of employee work-life balance.

    Our offices are designed as open, community-based spaces that work to connect employees while being immersed in our state-of-the-art laboratories.

    Whether you're in one of our collaboratively designed office spaces or working remotely, we thrive on connecting with each other to innovate.

    About Genmab

    Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics.

    For more than 20 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates.

    To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies.

    By 2030, Genmab's vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO) antibody medicines.

    Established in 1999, Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan.
    Our commitment to diversity, equity, and inclusion

    We are committed to fostering workplace diversity at all levels of the company and we believe it is essential for our continued success.

    No applicant shall be discriminated against or treated unfairly because of their race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), national origin, age, disability, or genetic information.

    Learn more about our commitments on our website .
    Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website

    .

    About Us

    Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics.

    For more than 20 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates.

    To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies.

    By 2030, Genmab's vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO) antibody medicines.

    Established in 1999, Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan.

    #J-18808-Ljbffr